Mentho Patch
FDA Label NDC 72602-002

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by The Egyptian Saudi Co For Medical Manufacturing Mascomid for the product Mentho Patch (NDC 72602-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding purpose, warnings, directions, stop use and ask doctor, storage, keep out of reach of children, active ingridient section, inactive ingredient section, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

For the temprorary releif of minor aches and pains of musceles and joints associated with simple backache, arthritis,strainsand sprains

Warnings

  • FOR EXTERNAL USE ONLY
  • When Using this Product
  • Avoid contact with eyes
  • Do not apply to open wounds, or to damaged skin
  • Do not bandage tightly.

Directions

  • Adults and children 3 years of age and older: apply to affected area not more than 3 to 4 times daily.
  • Children under 3 years of age: consult doctor.

Stop Use And Ask Doctor

  • If condition worsens
  • If symptoms persist more than 7 days or clear up and occur again with a few days

Storage

  • store in cool dry place avoid direct sunlight.

Keep Out Of Reach Of Children

If swallowed, get medical help or contact a Poison Control Center right away

Active Ingridient Section

Menthol,Camphor,Methyl salicylate

Inactive Ingredient Section

Glycerin ,Sodium poly acryl ate ,Aluminum chloride hex hydrate 2 ,
Anhydrous citric acid ,Tartaric acid 1 ,Poly sorbate -80 (tween 80) 0.5 ,Isopropyl myristate alcohol 2.5 ,Car boxy methyl cellulose (CMC) 2 
EDETA 0.5 ,Polyvinyl pyrolidone(PVP-K90) 3 ,Water 48.35 ,titanium dioxide 0.05,ACRYLATE/ C10-30 ALKYL ACRYLATE,cross polymer

* Please review the disclaimer below.